Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PE-001 Tablets in Adult Men With Premature Ejaculation
CTR20233521Phase 2Completed
- Sponsor
- 原研港
- Start
- Nov 2023
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of IC43 in premature ejaculation (PE), sponsored by 原研港. Started Nov 2023; status: completed.
02
Drugs
IC43
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on CTR20233521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233521.